Home/Filings/4/0000950142-17-001786
4//SEC Filing

Hargadon Robert Bernard 4

Accession 0000950142-17-001786

CIK 0001145460other

Filed

Oct 2, 8:00 PM ET

Accepted

Oct 3, 5:34 PM ET

Size

21.0 KB

Accession

0000950142-17-001786

Insider Transaction Report

Form 4
Period: 2017-10-03
Hargadon Robert Bernard
VP, Global Culture & Performan
Transactions
  • Disposition to Issuer

    Employee Stock Option (Right to Buy)

    2017-10-031,2500 total
    Exercise: $36.74Common Stock (1,250 underlying)
  • Disposition to Issuer

    Employee Stock Option (Right to Buy)

    2017-10-0320,0000 total
    Exercise: $29.55Common Stock (20,000 underlying)
  • Disposition to Issuer

    Employee Stock Option (Right to Buy)

    2017-10-0335,0000 total
    Exercise: $45.47Common Stock (35,000 underlying)
  • Disposition to Issuer

    Employee Stock Option (Right to Buy)

    2017-10-038000 total
    Exercise: $25.43Common Stock (800 underlying)
  • Disposition to Issuer

    Common Stock

    2017-10-0326,1900 total
  • Disposition to Issuer

    Employee Stock Option (Right to Buy)

    2017-10-035,0000 total
    Exercise: $26.06Common Stock (5,000 underlying)
  • Disposition to Issuer

    Employee Stock Option (Right to Buy)

    2017-10-039,6000 total
    Exercise: $25.68Common Stock (9,600 underlying)
  • Disposition to Issuer

    Restricted Stock Units

    2017-10-0316,3240 total
    Common Stock (16,324 underlying)
Footnotes (3)
  • [F1]Pursuant to that certain Agreement and Plan of Merger, dated as of January 30, 2016, as amended on April 13, 2017 (the "Merger Agreement"), between Alere Inc. (the "Company") and Abbott Laboratories, at the Effective Time (as defined in the Merger Agreement) (the "Effective Time"), each of these shares of the Company's common stock (the "Common Stock") was converted into the right to receive $51.00 (the "Merger Consideration").
  • [F2]Pursuant to the Merger Agreement, at the Effective Time, each outstanding Employee Stock Option, whether vested or unvested, was canceled and converted into the right to receive a lump-sum cash payment equal to the product of (i) the number of shares of Common Stock for which such Employee Stock Option has not been exercised and (ii) the excess, if any, of the Merger Consideration over the exercise price per share of such Employee Stock Option.
  • [F3]Each Restricted Stock Unit represents a contingent right to receive one share of Common Stock. Pursuant to the Merger Agreement, at the Effective Time, each outstanding Restricted Stock Unit was canceled and converted into the right to receive a lump-sum cash payment equal to the product of (i) the number of shares of Common Stock subject to such Restricted Stock Unit immediately prior to the Effective Time and (ii) the Merger Consideration.

Issuer

ALERE INC.

CIK 0001145460

Entity typeother

Related Parties

1
  • filerCIK 0001381471

Filing Metadata

Form type
4
Filed
Oct 2, 8:00 PM ET
Accepted
Oct 3, 5:34 PM ET
Size
21.0 KB